The Food and Drug Administration or FDA is responsible for assuring the public’s health as well as maintaining security of many different devices, drugs, and products. Although the individual's apart of the FDA are doing all that they can, with a change of policies there is room for a great deal of improvement. There are multiple different FDA policies that need to greatly improved to ensure the complete safety and health of the public. These policies include but are not limited to clinical trials, safety and effectiveness of drugs, and the independence of the FDA.
Any drug that wishes to be approved by the FDA must undergo 3 stages of clinical trials. The first stage takes place with a small amount of participants (15-100). These individuals receive low dosage in order to determine the correct amount needed to be effective when taken. Stage 2 is sent underway with a larger amount of volunteers (50-300). The goal of this phase is to determine whether the current drug is more effective than the drug currently found in the market. …show more content…
In order to keep track of these potential problems the FDA system receives many reports but unfortunately these reports are not of such great quality. The General Accounting Office stated, “weaknesses in FDA’s monitoring and enforcement process hamper its ability to effectively oversee post marketing studies. FDA has not routinely been reviewing sponsors’ annual submissions on the status of studies in a timely manner. It has little in the way of readily accessible, comprehensive data to monitor studies’ progression and does not consider such oversight a priority.” In order to improve the FDA system the creation of an easier system for detecting problems must be created and must frequently update the status of drug after it has been approved. But unfortunately no drug will be tested completely before it is put on the market. But the drugs that are approved have meet high standards of the
Any drug that wishes to be approved by the FDA must undergo 3 stages of clinical trials. The first stage takes place with a small amount of participants (15-100). These individuals receive low dosage in order to determine the correct amount needed to be effective when taken. Stage 2 is sent underway with a larger amount of volunteers (50-300). The goal of this phase is to determine whether the current drug is more effective than the drug currently found in the market. …show more content…
In order to keep track of these potential problems the FDA system receives many reports but unfortunately these reports are not of such great quality. The General Accounting Office stated, “weaknesses in FDA’s monitoring and enforcement process hamper its ability to effectively oversee post marketing studies. FDA has not routinely been reviewing sponsors’ annual submissions on the status of studies in a timely manner. It has little in the way of readily accessible, comprehensive data to monitor studies’ progression and does not consider such oversight a priority.” In order to improve the FDA system the creation of an easier system for detecting problems must be created and must frequently update the status of drug after it has been approved. But unfortunately no drug will be tested completely before it is put on the market. But the drugs that are approved have meet high standards of the